While our overall results indicate the possibility of better outcomes in patients with MRSA compared to non-MRSA, the only possibly significant difference was the higher likelihood of an early response in the MRSA group.
← all excerpts
Vancomycin AUC-Based Dosing Practices in a Non-Teaching Community Hospital and Associated Outcomes: A One-Year Survey of Uniform Targets for Infections with or without MRSA.
1
—
—